These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

947 related articles for article (PubMed ID: 27911274)

  • 21. Prognostic impact of intratumoral C-reactive protein expression in patients with clear cell renal cell carcinoma.
    Can C; Acikalin MF; Ozen A; Dundar E
    Urol Int; 2014; 92(3):270-5. PubMed ID: 24356040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of p21-activated kinase 6 expression in patients with clear cell renal cell carcinoma.
    Liu W; Liu H; Liu Y; Xu L; Zhang W; Zhu Y; Xu J; Gu J
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S575-83. PubMed ID: 24715215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma.
    Wang Z; Xie H; Zhou L; Liu Z; Fu H; Zhu Y; Xu L; Xu J
    Oncotarget; 2016 Aug; 7(32):51525-51534. PubMed ID: 27409666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-33 is associated with unfavorable postoperative survival of patients with clear-cell renal cell carcinoma.
    Wang Z; Xu L; Chang Y; Zhou L; Fu H; Zhang W; Yang Y; Xu J
    Tumour Biol; 2016 Aug; 37(8):11127-34. PubMed ID: 26926076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High expression of galectin-7 associates with poor overall survival in patients with non-metastatic clear-cell renal cell carcinoma.
    Wang J; Liu Y; Yang Y; Xu Z; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
    Oncotarget; 2016 Jul; 7(27):41986-41995. PubMed ID: 27259255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of MUC3A is associated with poor prognosis in localized clear-cell renal cell carcinoma.
    Niu T; Liu Y; Zhang Y; Fu Q; Liu Z; Wang Z; Fu H; Xu J; Liu K
    Oncotarget; 2016 Aug; 7(31):50017-50026. PubMed ID: 27374181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma.
    Fu H; Liu Y; Xu L; Liu W; Fu Q; Liu H; Zhang W; Xu J
    Tumour Biol; 2015 Aug; 36(8):5791-9. PubMed ID: 25716202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of the geriatric nutritional risk index in patients with non-metastatic clear cell renal cell carcinoma: a propensity score matching analysis.
    Zhou H; Lv D; Cui F; Qian Gong ; Li J; Wen J; Jia M; Kang Y; Rong Y; Zhang W; Shuang W
    Nutr J; 2024 Sep; 23(1):114. PubMed ID: 39342187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granulocyte macrophage colony-stimulating factor predicts postoperative recurrence of clear-cell renal cell carcinoma.
    Chang Y; Xu L; Zhou L; Fu Q; Liu Z; Yang Y; Lin Z; Xu J
    Oncotarget; 2016 Apr; 7(17):24527-36. PubMed ID: 27016418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma.
    Xia Y; Liu L; Long Q; Bai Q; Wang J; Xu J; Guo J
    Urol Oncol; 2016 Jan; 34(1):5.e1-9. PubMed ID: 26411550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of tumor-derived IL-1β and IL-18 in localized renal cell carcinoma: Associations with recurrence and survival.
    Xu L; Zhu Y; An H; Liu Y; Lin Z; Wang G; Xu J
    Urol Oncol; 2015 Feb; 33(2):68.e9-16. PubMed ID: 25241276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High expression of CXC chemokine receptor 6 associates with poor prognosis in patients with clear cell renal cell carcinoma.
    Chang Y; Zhou L; Xu L; Fu Q; Yang Y; Lin Z; Xu J
    Urol Oncol; 2017 Dec; 35(12):675.e17-675.e24. PubMed ID: 28918166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis.
    Becker A; Hickmann D; Hansen J; Meyer C; Rink M; Schmid M; Eichelberg C; Strini K; Chromecki T; Jesche J; Regier M; Randazzo M; Tilki D; Ahyai S; Dahlem R; Fisch M; Zigeuner R; Chun FK
    Eur J Surg Oncol; 2016 Mar; 42(3):419-25. PubMed ID: 26520403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IRF5 is associated with adverse postoperative prognosis of patients with non-metastatic clear cell renal cell carcinoma.
    Bai Q; Liu L; Xia Y; Wang J; Xi W; Qu Y; Xiong Y; Long Q; Xu J; Guo J
    Oncotarget; 2017 Jul; 8(27):44186-44194. PubMed ID: 28562332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of interleukin-8 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.
    An H; Zhu Y; Xie H; Liu Y; Liu W; Fu Q; Ye D; Xu J
    Tumour Biol; 2016 Apr; 37(4):4523-9. PubMed ID: 26503211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic nomogram for disease-free survival in patients with renal adenocarcinoma.
    Di Capua Sacoto C; Budia A; Garcia-Fadrique G; Lujan S; Ruiz-Cerdá JL; Jimenez-Cruz JF
    Urol Int; 2012; 88(3):271-6. PubMed ID: 22378354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of tissue-based biomarker signature in clear cell renal cell carcinoma.
    Haddad AQ; Luo JH; Krabbe LM; Darwish O; Gayed B; Youssef R; Kapur P; Rakheja D; Lotan Y; Sagalowsky A; Margulis V
    BJU Int; 2017 May; 119(5):741-747. PubMed ID: 28075543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of UTX expression in patients with clear cell renal cell carcinoma.
    Wang J; Liu L; Xi W; Long Q; Wang Y; Bai Q; Xia Y; Xu J; Guo J
    Urol Oncol; 2016 Aug; 34(8):338.e19-27. PubMed ID: 27106782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dot1l expression predicts adverse postoperative prognosis of patients with clear-cell renal cell carcinoma.
    Qu Y; Liu L; Wang J; Xi W; Xia Y; Bai Q; Xiong Y; Long Q; Xu J; Guo J
    Oncotarget; 2016 Dec; 7(51):84775-84784. PubMed ID: 27713173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.